Sector
PharmaceuticalsCMP
as on 03 Jul, 2024 12:00:00 AM
Open
₹134Prev. Close
₹133.36Turnover(Lac.)
₹248.97Day's High
₹136.75Day's Low
₹132.2552 Week's High
₹202.552 Week's Low
₹112.35Book Value
₹50.21Face Value
₹1Mkt Cap (₹ Cr.)
816.04P/E
229.48EPS
0.58Divi. Yield
014 Aug 2023
12:00 AM
AGM
Announcement Date: 14 Aug, 2023
13 May 2024
12:00 AM
Board Meeting
Agenda : Audited Result
14 Aug 2023
12:00 AM
BookCloser
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 27.78 | 27.78 | 27.78 | 59.92 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 297.87 | 387.32 | 480.39 | 832.82 |
Net Worth | 325.65 | 415.1 | 508.17 | 892.74 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 343.55 | 158.08 | 576.56 | 530.08 |
yoy growth (%) | 117.32 | -72.58 | 8.76 | -18.05 |
Raw materials | -176.26 | -58.52 | -196.99 | -168.83 |
As % of sales | 51.3 | 37.02 | 34.16 | 31.84 |
Employee costs | -59.47 | -46.64 | -136.73 | -132.2 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | -12.85 | -63.52 | -61.23 | -46.5 |
Depreciation | -26.57 | -26.9 | -57.04 | -66.14 |
Tax paid | -1.56 | -17.09 | -10.64 | 11.38 |
Working capital | -357.74 | 386.41 | -54.89 | 14.93 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 117.32 | -72.58 | 8.76 | -18.05 |
Op profit growth | -100.78 | -176.42 | 17.18 | -38.24 |
EBIT growth | -90.84 | -238.73 | -26.33 | -14.6 |
Net profit growth | -90.56 | 112.96 | -1.08 | -8,451.83 |
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|---|
Gross Sales | 559.17 | 459.95 | 661.23 | 624.81 | 544.06 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 559.17 | 459.95 | 661.23 | 624.81 | 544.06 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 61.83 | 154.32 | 1,687.18 | 10.06 | 30.02 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,529.35 | 120.29 | 3,65,682.64 | 867.6 | 0.89 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,563.25 | 76.97 | 1,21,312.5 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,484.25 | 32.36 | 1,20,195.02 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,094.25 | 31.35 | 1,08,114.81 | 1,405.2 | 0.28 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,503.95 | 24.48 | 1,06,298.05 | 1,034.8 | 0.63 | 5,081.8 | 1,453.02 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Rajesh Jain
Joint Managing Director
Sandeep Jain
Non-Exec. & Independent Dir.
R L Narasimhan
Non-Exec. & Independent Dir.
N N Khamitkar
Non-Exec. & Independent Dir.
K M Lal
Group CFO & Company Secretary
Vinod Goel
Non-Exec. & Independent Dir.
Manjula Upadhyay
Non-Exec. & Independent Dir.
Mukul Gupta
Whole-time Director
Ankesh Jain
Non-Exec. & Independent Dir.
BHUPINDER SINGH
Non Executive Director
Narotam Kumar Juneja
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Panacea Biotec Ltd
Summary
Indias leading research-based health management company with established research, manufacturing and marketing capabilities are collectively known as Panacea Biotec Limited (PBL), which was incorporated on 2nd February 1984 under the name of Panacea Drug (P) Ltd. A second largest vaccine producer in India has the product portfolio of highly innovative prescription products in important therapeutic areas such as pain management, diabetes management, renal-disease management, anti-osteoporosis, anti-tubercular, gastro-intestinal care products and vaccines. The Company has collaborations and tie-ups with leading national and international research organizations and corporations. PBL has ultra modern, state-of-art production facilities at Himachal Pradesh, Punjab & Delhi for manufacturing vaccines and pharmaceutical formulations comply with the US-FDA, UK-MHRA, SAMCC and WHO-cGMP standards and it has four research and development centers. The Company also has 24 product patents, valid in more than 60 countries worldwide. The plant for vaccines production (Radicura Pharma) and pharmaceutical formulations plant (Panacea Drug P Ltd) at New Delhi were established during the year 1988 and 1989 respectively. In 1993, merger of Panacea Drugs (P) Ltd and Radicura Pharma gave the name Panacea Biotec Ltd. The Company made its Initial Public Offering (IPO) in the year of 1995 and also in the same year, PBL had formed state -of the- art Drug Delivery R&D centre at Lalru. In the year 1997, th
Read More
What is the Panacea Biotec Ltd share price today?
The Panacea Biotec Ltd shares price on nse is Rs.₹133.23 today.
What is the Market Cap of Panacea Biotec Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Panacea Biotec Ltd is ₹816.04 Cr. as of 03 Jul ‘24
What is the PE and PB ratio of Panacea Biotec Ltd?
The PE and PB ratios of Panacea Biotec Ltd is 229.48 and 2.48 as of 03 Jul ‘24
What is the 52 Week High and Low of Panacea Biotec Ltd?
The 52-week high/low is the highest and lowest price at which a Panacea Biotec Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Panacea Biotec Ltd is ₹112.35 and ₹202.5 as of 03 Jul ‘24
What is the CAGR of Panacea Biotec Ltd?
Panacea Biotec Ltd's CAGR for 5 Years at -1.50%, 3 Years at -29.36%, 1 Year at 5.88%, 6 Month at -22.53%, 3 Month at -1.40% and 1 Month at 2.86%.
What is the shareholding pattern of Panacea Biotec Ltd?
The shareholding pattern of Panacea Biotec Ltd is as follows:
Promoters - 73.59 %
Institutions - 1.11 %
Public - 25.30 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
